| 发明名称 | Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts | ||
| 摘要 | The present invention relates to 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (II):; or a tautomer, solvate or hydrate thereof; and to its use for the treatment of non-Hodgkin's lymphoma. | ||
| 申请公布号 | US9636344(B2) | 申请公布日期 | 2017.05.02 |
| 申请号 | US201614990350 | 申请日期 | 2016.01.07 |
| 申请人 | Bayer Intellectual Property GmbH | 发明人 | Peters Jan-Georg;Militzer Hans-Christian;Müller Hartwig |
| 分类号 | A61K31/5377;C07D487/04;A61K45/06 | 主分类号 | A61K31/5377 |
| 代理机构 | Morrison and Foerster LLP | 代理人 | Morrison and Foerster LLP |
| 主权项 | 1. A method for the treatment of non-Hodgkin's lymphoma comprising administering to a patient in need thereof a therapeutically effective amount of a 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt or a solvate, hydrate or tautomer thereof. | ||
| 地址 | Monheim DE | ||